News | Endoscopes | March 14, 2019

Hologic Receives CE Mark for Three-in-One Omni Hysteroscope

Flexible, modular design with powerful visualization gives doctors a single device with three sheath options to both diagnose and treat patients

Hologic Receives CE Mark for Three-in-One Omni Hysteroscope

March 14, 2019 — Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with advanced visualization capabilities designed for both diagnostic and therapeutic hysteroscopic procedures. Obstetricians and gynecologists (ObGyns) can use the new Omni hysteroscope in out- and inpatient settings.

The Omni scope is designed to help ObGyns simplify the process of diagnosing and treating patients. Often, a surgeon requires a diagnostic scope to look in the uterine cavity for fibroids or polyps, then switches to an operative scope to biopsy or treat the pathology. With the new Omni scope, ObGyns can use the same scope with different sheath options to conveniently see and treat pathology.

Additional features include:

  • Premium MyoSure optics for quality visualization and clarity throughout the procedure;
  • Sheaths designed with smaller diameters (3.7 mm diagnostic sheath; 5.5 mm operative sheath; 6 mm operative sheath) to reduce dilation required and promote patient comfort and easy insertion;
  • Long 200 mm working length facilitates easier access and treatment for obese patients;
  • Simple assembly and disassembly so sheaths can be changed out easily between procedures;
  • Operative sheaths can be used with Hologic’s Aquilex hysteroscopic fluid management system; and
  • Compatible with all MyoSure tissue removal offerings including MyoSure Reach, MyoSure XL, MyoSure Lite, and MyoSure Manual devices.

For more information: www.hologic.com

Related Content

iCAD Reports Strong Momentum of ProFound AI for Digital Breast Tomosynthesis
News | Artificial Intelligence | March 26, 2019
iCAD Inc. reported strong adoption of its latest deep-learning, cancer detection software solution for digital breast...
Volpara Solutions Expands Relationship With GE Healthcare
News | Breast Density | March 26, 2019
Volpara Solutions announced the launch of an expanded agreement enabling the worldwide distribution of its...
Hologic Opens Learning and Experience Centre in Zaventem, Belgium
News | Women's Health | March 21, 2019
Hologic Inc. opened its first Learning and Experience Centre in Zaventem, Belgium. The state-of-the-art facility...
Researchers Use Radiomics to Predict Who Will Benefit from Chemotherapy
News | Radiomics | March 21, 2019
Using data from computed tomography (CT) images, researchers may be able to predict which lung cancer patients will...
QTbreasthealth Opens Breast Imaging Center in San Jose
News | Ultrasound Women's Health | March 20, 2019
QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for...
Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...